| 1 |
Abrocitinib |
1622902-68-4 |
4-Chloro-1H-pyrrolo[2,3-d]pyrimidine |
3680-69-1 |
| 2 |
Abrocitinib |
1622902-68-4 |
3-Oxocyclobutanecarboxylic acid |
23761-23-1 |
| 3 |
Abrocitinib |
1622902-68-4 |
Diphenylphosphoryl azide |
26386-88-9 |
| 4 |
Abrocitinib |
1622902-68-4 |
Propanesulfonyl chloride |
10147-36-1 |
| 5 |
Abrocitinib |
1622902-68-4 |
Beta Methallyl Alcohol |
513-42-8 |
| 6 |
Acamprosate Calcium |
77337-76-9 |
3-amino-1-Propanol |
156-87-3 |
| 7 |
Acamprosate Calcium |
77337-76-9 |
3-Chloropropylamine HCl |
6276-54-6 |
| 8 |
Alcaftadine |
147084-10-4 |
1-Phenethylimidazole |
49823-14-5 |
| 9 |
Alcaftadine |
147084-10-4 |
1-(Ethoxycarbonyl)-4-piperidinecarboxylic Acid |
118133-15-6 |
| 10 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
1-(4-Bromophenyl)piperidin-2-one |
27471-43-8 |
| 11 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
1-(4-Iodophenyl)-3-morpholino-5,6-dihydropyridin-2(1h)-one |
473927-69-4 |
| 12 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1h)-one |
536760-29-9 |
| 13 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1h)-one |
503615-03-0 |
| 14 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1h)-one |
545445-44-1 |
| 15 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
Ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylate |
473927-64-9 |
| 16 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate. |
27143-07-3 |
| 17 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
5-Chlorovaleryl Chloride |
1575-61-7 |
| 18 |
Apixaban/Apixaban Amorphous |
503612-47-3 |
5-Bromovaleryl Chloride |
4509-90-4 |
| 19 |
Atogepant |
1374248-81-3 |
tert-butyl ((3S,5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carb amate |
1456803-43-2 |
| 20 |
Atogepant |
1374248-81-3 |
(E)-1-(tert-butyl)-3-((5-chloro-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)pyridin-2-yl)methylene)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
1456804-07-1 |
| 21 |
Atogepant |
1374248-81-3 |
(6S)-6′-oxo-5,6,7,7′-tetrahydrospiro(cyclo penta[b]pyridine-6,5′-pyrrolo[2,3-d]pyrimidine-3-carboxylic acid |
1375541-21-1 |
| 22 |
Atogepant |
1374248-81-3 |
(3S,5S,6R)-6-Methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-aminium (S)-2-acetamido-3-phenylpropanoate |
1456803-45-4 |
| 23 |
Atogepant |
1374248-81-3 |
2, 2, 2-Trifluoroethyl Triflate |
6226-25-1 |
| 24 |
Atogepant |
1374248-81-3 |
1,3-BIS(DICYCLOHEXYLPHOSPHINO)PROPANE BIS(TETRAFLUOROBORATE) |
1002345-50-7 |
| 25 |
Atogepant |
1374248-81-3 |
2-Hydroxy-5-Nitrobenzaldehyde |
97-51-8 |
| 26 |
Baricitinib |
1187594-09-7 |
4-Chloro-7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidine |
941685-26-3 |
| 27 |
Baricitinib |
1187594-09-7 |
2-(1-(Ethylsulfonyl)Azetidin-3-ylidene)Acetonitrile |
1187595-85-2 |
| 28 |
Baricitinib |
1187594-09-7 |
1-(1-Ethoxyethyl)-4(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-YL)-1H-Pyrazole |
1029716-44-6 |
| 29 |
Bempedoic Acid |
738606-46-7 |
8-ISOCYANO-2,2,14,14-TETRAMETHYL-8- (TOLUENE-4-SULFONYL)- PENTADECANEDIOIC ACID DIETHYL ESTER (BP-03) N-2 |
738606-43-4 |
| 30 |
Bempedoic Acid |
738606-46-7 |
8-Oxo-2,2,14,14-tetramethylpentadecanedioic acid (BP-04) |
413624-71-2 |
| 31 |
Bepotastine Besilate |
190786-44-8 |
2-[(S)-(4-CHLOROPHENYL)( 4-PIPERIDINYLOXY) METHYL]PYRIDINE (BEO-S1) (BEP-Piperidine) |
201594-84-5 |
| 32 |
Besifloxacin |
405165-61-9 |
1-Cyclopropyl-1,4-dihydro-6,7-difluoro-4-oxoquinoline-3-carboxylic acid |
93107-30-3 |
| 33 |
Besifloxacin |
405165-61-9 |
(3R)-Azepan-3-amine Mandelate |
1429428-81-8 |
| 34 |
Brivaracetam |
357336-20-0 |
Cinchonidine |
485-71-2 |
| 35 |
Brivaracetam |
357336-20-0 |
R)-4-propyldihydrofuran- 2(3H)-one, |
63095-51-2 |
| 36 |
Canagliflozin |
842133-18-0 |
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene |
898566-17-1 |
| 37 |
Canagliflozin |
842133-18-0 |
2-(5-Bromo-2-methyl-benzyl)-5-(4-fluoro-phenyl)-thiophene |
1030825-20-7 |
| 38 |
Canagliflozin |
842133-18-0 |
2,3,4,6-Tetra-O-pivaloyl-Alpha-D-glucopyranosyl Bromide |
81058-27-7 |
| 39 |
Clopidogrel |
113665-84-2 |
2-chloro phenyl glycine methyl ester |
141109-14-0 |
| 40 |
Clopidogrel |
113665-84-2 |
S+(2-chlorophenyl) 2-(Thiophene-2-yl ethyl amino) acetic acid methyl ester.Hydrochloride |
141109-19-5 |
| 41 |
Dapagliflozin |
461432-26-8 |
5-Bromo-2-chloro-benzoic acid |
21739-92-4 |
| 42 |
Dapagliflozin |
461432-26-8 |
5-Bromo-2-Chloro-4-Ethoxydiphenylmethane (DP01) |
461432-23-5 |
| 43 |
Dapagliflozin |
461432-26-8 |
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconol Actone (DPS 01) |
32384-65-9 |
| 44 |
Dapagliflozin |
461432-26-8 |
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro- 3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran- 3,4,5-triyl triacetate (N-1) |
461432-25-7 |
| 45 |
Dapagliflozin |
461432-26-8 |
(1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4- chloro-3-[[4-[[(3S)-tetrahy drofu-ran-3- yl]oxy]phenyl] methyl]phenyl]-D-Glucitol (Acetoxy Empagliflozin) |
915095-99-7 |
| 46 |
Dapagliflozin |
461432-26-8 |
S (+) 1,2-PROPANEDIOL |
4254-15-3 |
| 47 |
Deucravacitinib |
1609392-27-9 |
2-Methoxy-3-nitrobenzamide |
722538-98-9 |
| 48 |
Deucravacitinib |
1609392-27-9 |
2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline |
1609394-10-6 |
| 49 |
Deucravacitinib |
1609392-27-9 |
Methyl 2-Hydroxy-3-Nitrobenzoate |
22621-41-6 |
| 50 |
Deucravacitinib |
1609392-27-9 |
Cyclopropanecarboxamide |
6228-73-5 |
| 51 |
Deucravacitinib |
1609392-27-9 |
Potassium phosphate, tribasic |
7778-53-2 |
| 52 |
Deucravacitinib |
1609392-27-9 |
Xantphos |
161265-03-8 |
| 53 |
Deucravacitinib |
1609392-27-9 |
1,1-BIS(DICYCLOHEXYLPHOSPHINO)FERROCENE |
146960-90-9 |
| 54 |
Deucravacitinib |
1609392-27-9 |
4,6-Dichloro-N-(methyl-d3)-3-pyridazinecarboxamide |
1609393-89-6 |
| 55 |
Deucravacitinib |
1609392-27-9 |
N-Acetyl-L-cysteine |
616-91-1 |
| 56 |
Difluprednate |
23674-86-4 |
6-alpha-fluoro-isoflupredone |
806-29-1 |
| 57 |
Edoxaban |
480449-70-5 |
5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride (EDO-S3) |
720720-96-7 |
| 58 |
Edoxaban |
480449-70-5 |
Ethyl 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetate Hydrochloride (EDO-S2) |
1243308-37-3 |
| 59 |
Edoxaban |
480449-70-5 |
Tert-Butyl{1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexy]carbamate oxalate (EDO-S1) |
1210348-34-7 |
| 60 |
Edoxaban |
480449-70-5 |
tert-Butyl ((1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate |
365998-36-3 |
| 61 |
Eltrombopag |
496775-62-3 |
2-HYDROXY-3″-NITRO-BIPHENYL-3- CARBOXYLIC ACID |
376591-95-6 |
| 62 |
Eltrombopag |
496775-62-3 |
3-Carboxyphenylboronic acid |
25487-66-5 |
| 63 |
Eltrombopag |
496775-62-3 |
1-Bromo-2-methoxy-3-nitrobenzene |
98775-19-0 |
| 64 |
Eltrombopag |
496775-62-3 |
3,4-Dimethylphenyl hydrazine Hydorchloride (KSM) |
60481-51-8 |
| 65 |
Eltrombopag |
496775-62-3 |
2-(3,4-Dimethylphenyl)-5-methyl-1,2-dihydro-3H-pyrazol-3-one |
277299-70-4 |
| 66 |
Eltrombopag |
496775-62-3 |
3′-Amino-2′-hydroxybiphenyl-3-carboxylic acid. HCl |
376591-97-8 |
| 67 |
Empagliflozin |
864070-44-0 |
(S)-3-Hydroxytetrahydrofuran |
86087-23-2 |
| 68 |
Empagliflozin |
864070-44-0 |
(1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahy drofu-ran-3-yl]oxy]phenyl] methyl]phenyl]-Dglucitol TetraAcetate (N-1) |
915095-99-7 |
| 69 |
Finerenone |
1050477-31-0 |
(Z)-2-Cyanothyl 2-(4-Cyano-2-Methoxybenzylidene)-3-Oxobutanote |
1050477-39-8 |
| 70 |
Finerenone |
1050477-31-0 |
4-(4-Cyano-2-Methoxyphenyl)-5-Ethoxy-2,8-Dimethyl-1,4-Dihydro-1,6-Naphthyidine-3-Carboxylic Acid |
1050477-45-6 |
| 71 |
Finerenone |
1050477-31-0 |
4-(4-Cyano-2-Methoxyphenyl)-5-Ethoxy-2,8-Dimethyl-1,4-Dihydro-1,6-Naphthyridine-3-Carboxamide |
1050477-27-4 |
| 72 |
Finerenone |
1050477-31-0 |
1-Methylpiperazine |
109-01-3 |
| 73 |
Finerenone |
1050477-31-0 |
2-Cyanoethyl-3-Oxobutanote |
65193-87-5 |
| 74 |
Finerenone |
1050477-31-0 |
4-Formyl-3-Methoxy-Benzonitrile |
21962-45-8 |
| 75 |
Finerenone |
1050477-31-0 |
4-Amino-2-Hydroxy-5-Methylpyridine |
95306-64-2 |
| 76 |
Fezolinetant |
1629229-37-3 |
Ethyl 3-methyl-1,2,4-thiadiazole-5-carboxylate |
76162-56-6 |
| 77 |
Fezolinetant |
1629229-37-3 |
3-Methyl-1,2,4-thiadiazole-5-carboxylic acid hydrazide |
1375066-73-1 |
| 78 |
Fezolinetant |
1629229-37-3 |
(R)-4-(2,4-dimethoxybenzyl)-3-methylpiperazin-2-one |
1383146-20-0 |
| 79 |
Fezolinetant |
1629229-37-3 |
(R)-3-Methyl-2-oxo-piperazine |
922178-61-8 |
| 80 |
Lafutidine |
206449-93-6 |
N-{4-[4-(Piperidinomethyl) pyridyl-2-oxy]-cis-2-butene} phthalimide maleic acid |
146447-26-9 |
| 81 |
Lafutidine |
206449-93-6 |
P-Nitrophenyl-2- (furfuryl sulfinyl) acetic acid |
123855-55-0 |
| 82 |
Lasmiditan |
439239-90-4 |
2,4,6-Trifluorobenzoylchloride |
79538-29-7 |
| 83 |
Lasmiditan |
439239-90-4 |
(6-Aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone dihydrochloride |
613678-10-7 |
| 84 |
Lasmiditan |
439239-90-4 |
2,4,6-trifluorobenzoic acid |
28314-80-9 |
| 85 |
Linagliptin |
668270-12-0 |
2-Chloromethyl)-4-Methylquinazoline |
109113-72-6 |
| 86 |
Linagliptin |
668270-12-0 |
8-bromo-7-(2-butyn-1-yl)-3,7-di hydro-3-methyl-1H-Purine-2,6-dione (LGS 01) |
666816-98-4 |
| 87 |
Linagliptin |
668270-12-0 |
(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate (BOC-Linagliptin) (N-1) |
668273-75-4 |
| 88 |
Linagliptin |
668270-12-0 |
3-Methyl Xanthine |
1076-22-8 |
| 89 |
Linagliptin |
668270-12-0 |
( R)-3-(Boc-Amino)piperidine |
309956-78-3 |
| 90 |
Linagliptin |
668270-12-0 |
R)-3-Amino-piperidine dihydrochloride 334618-23-4 |
33461823-4 |
| 91 |
Linagliptin |
668270-12-0 |
Di-Tert Butyl Dicarbonate (BOC Anhydride) |
24424-99-5 |
| 92 |
Mirtazapine |
61337-67-5 |
1-Methyl-3-Phenyl Piperazine (NM3PP) |
5271-27-2 |
| 93 |
Mirtazapine |
61337-67-5 |
1-(3-Hydroxymethylpyridin-2-yl)-4-methyl-2-phenylpiperazine (HMPPMP) |
61337-89-1 |
| 94 |
Moxonidine |
75438-57-2 |
4,6-Dichloro-2-Methylpyrimidin-5-Amine (MOX-S1) |
39906-04-2 |
| 95 |
Moxonidine |
75438-57-2 |
1-Acetyl-2-Imidazolidinone (MOX-S2) |
5391-39-9 |
| 96 |
Nintedanib/Nintedanib Esylate |
656247-17-5 |
TRIMETHYL O-BENZOATE |
707-07-3 |
| 97 |
Nintedanib/Nintedanib Esylate |
656247-17-5 |
N-METHYL-2-(4-METHYLPIPERAZINE-1-YL-)-N-(4-AMINOPHENYL)ACETAMIDE |
262368-30-9 |
| 98 |
Nintedanib/Nintedanib Esylate |
656247-17-5 |
6-METHOXYCARBONYL-2-OXINDOLE |
14192-26-8 |
| 99 |
Nintedanib/Nintedanib Esylate |
656247-17-5 |
METHYL 1-ACETYL-2-OXOINDOLINE-6-CARBOXYLATE |
676326-36-6 |
| 100 |
Nintedanib/Nintedanib Esylate |
656247-17-5 |
(Z)-3-[(4-{Methyl-[2-(4-methylpiperazin-1-yl)acetyl] amino}-phenylamino)-methylene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic Acid Methyl Ester |
656247-18-6 |
| 101 |
Olmesartan/Olmesartan Medoxomil |
144689-63-4 |
Ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-4-carboxylate (IDE) (OL01) |
144689-93-0 |
| 102 |
Olmesartan/Olmesartan Medoxomil |
144689-63-4 |
4-Chloromethyl-5-methyl-[1,3]dioxol-2-one (DMDO CL) (CMMDO) |
80841-78-7 |
| 103 |
Oxcarbazepine |
28721-07-5 |
10 methoxy iminostilbene |
4698-11-7 |
| 104 |
Oxcarbazepine |
28721-07-5 |
Iminodibenzyl (IDB) |
494-19-9 |
| 105 |
Oxcarbazepine |
28721-07-5 |
Iminodibenzyl Carbonyl Chloride |
33949-19-5 |
| 106 |
Posaconazole |
171228-49-2 |
1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine (KSM) |
74853-08-0 |
| 107 |
Posaconazole |
171228-49-2 |
N’-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide oxalate (KSM) |
1887197-42-3 |
| 108 |
Posaconazole |
171228-49-2 |
2-(2-(2,6-difluorophenyl)allyl) propane-1,3-diol (KSM) |
165115-73-1 |
| 109 |
Resmetirom |
920509-32-6 |
4-Amino-2,6-Dichlorophenol |
5930-28-9 |
| 110 |
Resmetirom |
920509-32-6 |
3,6-Dichloro-4-Isopropylpyridazine |
107228-51-3 |
| 111 |
Resmetirom |
920509-32-6 |
N-CyanoAcetylurethane |
6629-04-5 |
| 112 |
Resmetirom |
920509-32-6 |
Benzenamine,3,5-Dichloro-4-[[6-Chloro-5(1-Methylethyl)-3-Pyridazinyl]oxy] |
920509-27-9 |
| 113 |
Resmetirom |
920509-32-6 |
3(2H)-Pyridazinone,6-(4-Amino-2,6-Dichlorophenoxy)-4-(1-Methylethyl) |
920509-28-0 |
| 114 |
Resmetirom |
920509-32-6 |
(Z)-Ethyl(2-Cyano-2-(2-(3,5-Dichloo-4-((5-Isopropyl-6-Oxox-1,66-Dihydropyridazin-3yl)oxy)Phenyl)Hydrazono)Acetyl)Caarbamate |
920509-33-7 |
| 115 |
Resmetirom |
920509-32-6 |
1,2,4-Triazine-6-carbonitrile,2-{3,5-Dichloro-4[[1,6-Dihydro-5-(1-Methylethyl)-6-Oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-Tetrahydro-3,5-Dioxo |
920509-32-6 |
| 116 |
Rimegepant |
1289023-67-1 |
(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine |
1289024-42-5 |
| 117 |
Rimegepant |
1289023-67-1 |
5H-Cyclohepta[b]pyridin-9-ol, 5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-, dihydrochloride, (5S,6S,9R)- |
1373116-07-4 |
| 118 |
Rimegepant |
1289023-67-1 |
2H-Imidazo[4,5-b]pyridin-2-one, 1,3-dihydro-1-[1-(1H-imidazol-1-ylcarbonyl)-4-piperidinyl] |
1373116-06-3 |
| 119 |
Rimegepant |
1289023-67-1 |
7,8-Dihydro-5H-cyclohepta[ b]pyridine-5,9(6H)-dione |
39713-40-1 |
| 120 |
Ripasudil Hydrochloride Hydrate |
223645-67-8 |
4-Fluoroisoquinoline |
394-67-2 |
| 121 |
Ripasudil Hydrochloride Hydrate |
223645-67-8 |
4-Fluoroisoquinoline sulfate |
906820-09-5 |
| 122 |
Ripasudil Hydrochloride Hydrate |
223645-67-8 |
Hexahydro-2(S)-methyl-4-(t-butoxycarboxyl)-1,4-diazepine |
194032-32-1 |
| 123 |
Ripasudil Hydrochloride Hydrate |
223645-67-8 |
4-Fluoro-5-isoquinolinesulfonyl chloride hydrochloride (1:1) |
906820-08-4 |
| 124 |
Risperidone |
106266-06-2 |
3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride |
93076-03-0 |
| 125 |
Risperidone |
106266-06-2 |
Fluoro-4-methoxy-benzyl-piperidine hcl |
84163-13-3 |
| 126 |
Rivaroxaban |
366789-02-8 |
4- (4-Amino Phenyl) Morpholin-3-one |
438056-69-0 |
| 127 |
Rivaroxaban |
366789-02-8 |
2-[(2S)-2-oxiranylmethyl]-1H-isoindole-1,3(2H)-dione. OR (S)-(+)-N-(2,3-EPOXYPROPYL) PHTHALIMIDE |
161596-47-0 |
| 128 |
Rivaroxaban |
366789-02-8 |
5-Chlorothiophene-2-carboxylic acid |
24065-33-6 |
| 129 |
Rufinamide |
106308-44-5 |
2,6-Difluorobenzyl Bromide |
85118-00-9 |
| 130 |
Rufinamide |
106308-44-5 |
2,6-Difluorobenzyl chloride |
697-73-4 |
| 131 |
Rufinamide |
106308-44-5 |
2-chloroacrytonitrile |
920-37-6 |
| 132 |
Sacubitril |
149709-62-6 |
(R,E)-5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid |
1012341-48-8 |
| 133 |
Sacubitril |
149709-62-6 |
2R,4S)-2-Methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic Acid (N-2) |
1012341-50-2 |
| 134 |
Saxagliptin |
709031-78-7 |
(1S,3S,5S ) –2-AZABICYCLO[3,1,0]-HEXANE-3-CARBOXAMIDE TRIFLUOROACETATE (SXS01) |
361440-69-9 |
| 135 |
Saxagliptin |
709031-78-7 |
(Alphas)-Alpha[[(1,1-Dimethyethoxy)Carbomyl]Amino]-3-Hydroxytricylo[3,31,13,7]Decane-1-Acetic Acid- (SX00) |
361442-00-4 |
| 136 |
Saxagliptin |
709031-78-7 |
tert-butyl (1S,3S,5S)-3-Carbamoyl-2-aza-bicyclo[3.1.0]hexane-2-carboxylate |
361440-67-7 |
| 137 |
Silodosin |
160970-54-7 |
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate |
239463-85-5 |
| 138 |
Silodosin |
160970-54-7 |
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate |
160969-03-9 |
| 139 |
Semaglutide |
910463-68-2 |
Arg34 GLP-19-37 POLY PEPTIDE(P29) |
1169630-82-3 |
| 140 |
Semaglutide |
910463-68-2 |
(S)-22-(TERT-BUTOXYCARBONYL )-10,19,24-TRIOXO-3,6,12 ,15-TETRAOXA- 9,18,23 -TRIAZAHENTETR |
1118767-16-0 |
| 141 |
Sitagliptin |
486460-32-6 |
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |
762240-92-6 |
| 142 |
Sitagliptin |
486460-32-6 |
(R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid |
486460-00-8 |
| 143 |
Solifenacin |
242478-38-2 |
(R)-(-)-3-Quinuclidinol |
25333-42-0 |
| 144 |
Tafamidis/Tafamidis Meglumine |
594839-88-0 |
4-amino-3-Hydroxy benzoic acid |
2374-03-0 |
| 145 |
Tafamidis/Tafamidis Meglumine |
594839-88-0 |
Methyl 4-amino-3-hydroxybenzoate |
63435-16-5 |
| 146 |
Tafamidis/Tafamidis Meglumine |
594839-88-0 |
3,5-Dichlorobenzoyl chloride |
2905-62-6 |
| 147 |
Tafamidis/Tafamidis Meglumine |
594839-88-0 |
4-(3,5-Dichlorobenzamido)-3-hydroxybenzoic acid |
1184581-58-5 |
| 148 |
Tafamidis/Tafamidis Meglumine |
594839-88-0 |
N-Methyl-D-glucamine (Meglumine) |
6284-40-8 |
| 149 |
Tapinarof (also known as benvitimod) |
79338-84-4 |
3,5-Dihydroxybenzoic acid / α-Resorcylic acid / 5-Carboxyresorcinol; |
99-10-5 |
| 150 |
Tapinarof (also known as benvitimod) |
79338-84-4 |
3,5-Dimethoxybenzoic acid methyl ester |
2150-37-0 |
| 151 |
Tapinarof (also known as benvitimod) |
79338-84-4 |
Methyl 3,5-dimethoxy-4-(1-methylethyl)benzoate |
344396-17-4 |
| 152 |
Tapinarof (also known as benvitimod) |
79338-84-4 |
3,5-Dimethoxy-4-(1-methylethyl)benzenemethanol |
344396-18-5 |
| 153 |
Tegoprazan |
942195-55-3 |
4-Hydroxy-N,N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-1H-benzimidazole-6-carboxamide |
942195-86-0 |
| 154 |
Tegoprazan |
942195-55-3 |
(4R)-5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-ol |
1270294-05-7 |
| 155 |
Tegoprazan |
942195-55-3 |
4-Hydroxy-2-methyl-1-(phenylmethyl)-1H-benzimidazole-6-carboxylic acid |
1640981-19-6 |
| 156 |
Tegoprazan |
942195-55-3 |
1,1-(Azodicarbonyl)-dipiperidine (ADDP) |
10465-81-3 |
| 157 |
Tofacitinib |
477600-75-2 |
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine- TF 01 (Tosylate) |
479633-63-1 |
| 158 |
Tofacitinib |
477600-75-2 |
(3R,4R)- N,4-dimethyl-1-(phenylmethyl)-3-Piperidinamine hydrochloride (1:2) |
1062580-52-2 |
| 159 |
Tofacitinib |
477600-75-2 |
4-chloro-7H-Pyrrolo[2,3-d]pyrimidine (TOF-S1) |
3680-69-1 |
| 160 |
Tofacitinib |
477600-75-2 |
(3R,4R)-Bdimethylpiperidin-3-enzyl-N,4-amine |
477600-71-8 |
| 161 |
Tofacitinib |
477600-75-2 |
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (TF03) |
477600-74-1 |
| 162 |
Tofacitinib |
477600-75-2 |
N-((3R,4R)-1-benzyl-4-methylpiperidin-3- yl)-N-methyl-7H-pyrrolo(2,3-d)pyrimidin- 4-amine (N-2) |
477600- 73-0 |
| 163 |
Tofacitinib |
477600-75-2 |
Tofacitinib Citrate |
540737-29-9 |
| 164 |
Torsamide |
56211-40-6 |
4-Chloro-3-Pyridine Sulfonamide |
33263-43-3 |
| 165 |
Torsamide |
56211-40-6 |
4-[(3-methyl phenyl)amino]-3-pyridinesulfonamide [MPAPS] |
72811-73-5 |
| 166 |
Vericiguat |
1350653-20-1 |
2-{5-fluoro-1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidine-4,5,6-triamine N-1 |
1350653-30-3 |
| 167 |
Vericiguat |
1350653-20-1 |
2-5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo 3,4-b pyridin-3-yl) -5-1 (E)-phenyldiazenyl pyrimidine-4,6-diamine N-2 |
1350653-29-0 |
| 168 |
Vericiguat |
1350653-20-1 |
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide N-3 |
1350653-27-8 |
| 169 |
Vericiguat |
1350653-20-1 |
5-FLUORO-1-[(2-FLUOROPHENYL)METHYL]-1H-PYRAZOLO[3,4-b] PYRIDINE-3-CARBONITRILE |
1350653-26-7 |
| 170 |
Vonoprazan |
881681-00-1 |
5-(2-Fluoro-phenyl)-1H-pyrrole-3-carbaldehyde |
881674-56-2 |
| 171 |
Vonoprazan |
881681-00-1 |
Pyridine-3-sulfonyl chloride |
16133-25-8 |
| 172 |
Vortioxetine Hydrobromide |
960203-27-4 |
O-Bromo Iodo Benzene (1-Bromo-2-Iodobenzene) |
583-55-1 |
| 173 |
Vortioxetine Hydrobromide |
960203-27-4 |
1.1′-Binaphthyl-2.2-Diphemyl Phospine (2,2′-BIS(DIPHENYLPHOSPHINO)-1,1′-BINAPHTHYL) / R-Binap |
98327-87-8 |
| 174 |
Vortioxetine Hydrobromide |
960203-27-4 |
2,4-dimethylthiophenol (VXS01) |
13616-82-5 |
| 175 |
Vortioxetine Hydrobromide |
960203-27-4 |
N-Butyloxycarbonyl amino Piperazine (1-BOC Piperazine) |
57260-71-6 |
| 176 |
Vortioxetine Hydrobromide |
960203-27-4 |
Ortho DI Chloro Benzene – 99.5 (1,2-Dichloro Benzene) |
95-50-1 |
| 177 |
Vortioxetine Hydrobromide |
960203-27-4 |
1-Chloro-2-Nitrobenzene |
88-73-3 |
| 178 |
Vortioxetine Hydrobromide |
960203-27-4 |
N,N- Bis(2-chloroethyl)amine hydrochloride |
821-48-7 |
| 179 |
Zavegepant Hydrochloride |
1414976-20-7 |
Methyl (2R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate dihydrochloride |
1414976-14-9 |
| 180 |
Zavegepant Hydrochloride |
1414976-20-7 |
3-(piperidin-4-yl)quinolin-2(1H)-one hydrochloride |
855778-84-6 |
| 181 |
Zavegepant Hydrochloride |
1414976-20-7 |
1-(1-Methylpiperidin-4-yl)piperazine trihydrochloride |
349535-15-5 |
| 182 |
Zavegepant Hydrochloride |
1414976-20-7 |
(R)-methyl 2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate |
890044-58-3 |
| 183 |
Zavegepant Hydrochloride |
1414976-20-7 |
(2R)-2-Amino-3-(7-methyl-1Hindazol-5-yl)propanoic acid |
1061710-38-0 |